| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A heterologous prime–boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36/LACK antigen protects BALB/c mice from cutaneous leishmaniasis
|
Gonzalo, Rosa M
|
|
2002
|
20 |
7-8 |
p. 1226-1231
6 p.
|
artikel
|
| 2 |
A new accelerated vaccination schedule for rapid protection against hepatitis A and B
|
Nothdurft, H.D
|
|
2002
|
20 |
7-8 |
p. 1157-1162
6 p.
|
artikel
|
| 3 |
Announcement: Microarrays Immune Response
|
|
|
2002
|
20 |
7-8 |
p. XXXVI-
1 p.
|
artikel
|
| 4 |
Announcement: Therapeutic Vaccine agains
|
|
|
2002
|
20 |
7-8 |
p. XXXVII-
1 p.
|
artikel
|
| 5 |
A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants
|
Dus Santos, Marı́a J
|
|
2002
|
20 |
7-8 |
p. 1141-1147
7 p.
|
artikel
|
| 6 |
A simple selection system for construction of recombinant gD-negative pseudorabies virus as a vaccine vector
|
Shiau, Ai-Li
|
|
2002
|
20 |
7-8 |
p. 1186-1195
10 p.
|
artikel
|
| 7 |
Author Index (to Vol. 19,2001)
|
|
|
2002
|
20 |
7-8 |
p. I-XVI
nvt p.
|
artikel
|
| 8 |
Clinical proof of principle for ChimeriVax™: recombinant live, attenuated vaccines against flavivirus infections
|
Monath, Thomas P
|
|
2002
|
20 |
7-8 |
p. 1004-1018
15 p.
|
artikel
|
| 9 |
Comparison of antibody titers after immunization with monovalent or tetravalent KLH conjugate vaccines
|
Ragupathi, Govindaswami
|
|
2002
|
20 |
7-8 |
p. 1030-1038
9 p.
|
artikel
|
| 10 |
Construction and in vitro characterization of a molecularly cloned human immunodeficiency virus type 1 library
|
Mukai, Tetsu
|
|
2002
|
20 |
7-8 |
p. 1181-1185
5 p.
|
artikel
|
| 11 |
Construction of recombinant targeting immunogens incorporating an HIV-1 neutralizing epitope into sites of differing conformational constraint
|
Ho, Jason
|
|
2002
|
20 |
7-8 |
p. 1169-1180
12 p.
|
artikel
|
| 12 |
Continuous antigen delivery from controlled release implants induces significant and anamnestic immune responses
|
Kemp, J.M
|
|
2002
|
20 |
7-8 |
p. 1089-1098
10 p.
|
artikel
|
| 13 |
Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine
|
Konishi, Eiji
|
|
2002
|
20 |
7-8 |
p. 1058-1067
10 p.
|
artikel
|
| 14 |
DNA vaccination with map1 gene followed by protein boost augments protection against challenge with Cowdria ruminantium, the agent of heartwater
|
Nyika, Aceme
|
|
2002
|
20 |
7-8 |
p. 1215-1225
11 p.
|
artikel
|
| 15 |
Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime–boost immunisation regimes
|
Gilbert, Sarah C
|
|
2002
|
20 |
7-8 |
p. 1039-1045
7 p.
|
artikel
|
| 16 |
Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults
|
Treanor, John
|
|
2002
|
20 |
7-8 |
p. 1099-1105
7 p.
|
artikel
|
| 17 |
Evaluation of immunization practices in Naples–Italy
|
Simonetti, Andrea
|
|
2002
|
20 |
7-8 |
p. 1046-1049
4 p.
|
artikel
|
| 18 |
Familial adverse events after measles–mumps–rubella (MMR) vaccination
|
Guala, Andrea
|
|
2002
|
20 |
7-8 |
p. 991-
1 p.
|
artikel
|
| 19 |
Frequency and causes of vaccine wastage
|
Setia, Sabeena
|
|
2002
|
20 |
7-8 |
p. 1148-1156
9 p.
|
artikel
|
| 20 |
Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing
|
Pugachev, Konstantin V
|
|
2002
|
20 |
7-8 |
p. 996-999
4 p.
|
artikel
|
| 21 |
Human therapeutic cocaine vaccine: safety and immunogenicity
|
Kosten, Thomas R
|
|
2002
|
20 |
7-8 |
p. 1196-1204
9 p.
|
artikel
|
| 22 |
Immunogenicity of second dose measles–mumps–rubella (MMR) vaccine and implications for serosurveillance
|
Pebody, R.G
|
|
2002
|
20 |
7-8 |
p. 1134-1140
7 p.
|
artikel
|
| 23 |
Impact of a regional Hib vaccination programme in Italy
|
Gallo, Giovanni
|
|
2002
|
20 |
7-8 |
p. 993-995
3 p.
|
artikel
|
| 24 |
Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis
|
Buddle, Bryce M
|
|
2002
|
20 |
7-8 |
p. 1126-1133
8 p.
|
artikel
|
| 25 |
Integrity of GH-loop of foot-and-mouth disease virus during virus inactivation: detection by epitope specific antibodies
|
Patil, P.K
|
|
2002
|
20 |
7-8 |
p. 1163-1168
6 p.
|
artikel
|
| 26 |
Keyword Index to: Volume 19
|
|
|
2002
|
20 |
7-8 |
p. XVII-XXXV
nvt p.
|
artikel
|
| 27 |
Lactogenic antibody responses in cows vaccinated with recombinant bovine rotavirus-like particles (VLPs) of two serotypes or inactivated bovine rotavirus vaccines
|
Kim, Y
|
|
2002
|
20 |
7-8 |
p. 1248-1258
11 p.
|
artikel
|
| 28 |
Mucosal [SIgA] and serum [IgG] immunologic responses in the community after a single intra-nasal immunization with a new inactivated trivalent influenza vaccine
|
Greenbaum, Evgenia
|
|
2002
|
20 |
7-8 |
p. 1232-1239
8 p.
|
artikel
|
| 29 |
Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine
|
Lu, Xiuhua
|
|
2002
|
20 |
7-8 |
p. 1019-1029
11 p.
|
artikel
|
| 30 |
Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad–Zagreb mumps strain
|
da Cunha, Sérgio Souza
|
|
2002
|
20 |
7-8 |
p. 1106-1112
7 p.
|
artikel
|
| 31 |
Oxidised mannan as a novel adjuvant inducing mucosal IgA production
|
Stambas, John
|
|
2002
|
20 |
7-8 |
p. 1068-1078
11 p.
|
artikel
|
| 32 |
Persistent infection of influenza virus in irradiated mice and its prevention by intranasal vaccination
|
Hasegawa, Hideki
|
|
2002
|
20 |
7-8 |
p. 1050-1057
8 p.
|
artikel
|
| 33 |
Protection induced by intramuscular immunization with DNA vaccines of pseudorabies in mice, rabbits and piglets
|
Hong, Wenzhou
|
|
2002
|
20 |
7-8 |
p. 1205-1214
10 p.
|
artikel
|
| 34 |
Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children
|
Halperin, Scott A
|
|
2002
|
20 |
7-8 |
p. 1240-1247
8 p.
|
artikel
|
| 35 |
The cost-effectiveness of varicella vaccination in Canada
|
Brisson, M
|
|
2002
|
20 |
7-8 |
p. 1113-1125
13 p.
|
artikel
|
| 36 |
The protective efficacy of a recombinant VP2-based African horsesickness subunit vaccine candidate is determined by adjuvant
|
Scanlen, M
|
|
2002
|
20 |
7-8 |
p. 1079-1088
10 p.
|
artikel
|
| 37 |
Vaccination of foals and pregnant mares with Duvaxyn EHV1, 4 vaccine
|
Studdert, Michael J
|
|
2002
|
20 |
7-8 |
p. 992-
1 p.
|
artikel
|
| 38 |
Vaccine quality—can a single standard be defined?
|
Milstien, Julie
|
|
2002
|
20 |
7-8 |
p. 1000-1003
4 p.
|
artikel
|
Tijdschrift beschrijving